Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: post hoc analyses of three placebo-controlled studies
Michael E Thase,1 Emmanuelle Weiller,2 Peter Zhang,3 Catherine Weiss,4 Roger S McIntyre5 1Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania and the Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, USA; 2Medical Affairs, H. Lundbeck A/S, Valby, Copenhag...
Main Authors: | Thase ME, Weiller E, Zhang P, Weiss C, McIntyre RS |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-12-01
|
Series: | Neuropsychiatric Disease and Treatment |
Subjects: | |
Online Access: | https://www.dovepress.com/adjunctive-brexpiprazole-in-patients-with-major-depressive-disorder-an-peer-reviewed-article-NDT |
Similar Items
-
Adjunctive antidepressive pharmacotherapy in schizophrenia patients
by: M. Zink
Published: (2021-04-01) -
Functional neuroimaging biomarkers of anhedonia response to escitalopram plus adjunct aripiprazole treatment for major depressive disorder
by: Sophie R. Vaccarino, et al.
Published: (2024-01-01) -
Functioning outcomes with adjunctive treatments for major depressive disorder: a systematic review of randomized placebo-controlled studies
by: Weiller E, et al.
Published: (2017-12-01) -
Real-World Economic Outcomes of Brexpiprazole and Extended-Release Quetiapine Adjunctive Use in Major Depressive Disorder
by: Seetasith A, et al.
Published: (2019-12-01) -
Impressive Response with Brexpiprazole in Ekbom’s syndrome
by: J. Hsiao, et al.
Published: (2022-06-01)